Shrieve Chemical Company

Overview

Deal Type Mergers & Acquisitions
Corporate Banking
Client & Transactional Partners Shrieve Chemical Company
Gemspring Capital
Our Role Exclusive Sell-Side Advisor

Summary

On December 2, 2019, KeyBanc Capital Markets (“KBCM”) successfully completed the sale of a majority interest in Shrieve Chemical Company, LLC (“Shrieve”) to Gemspring Capital (“Gemspring”).

KBCM was chosen to serve as exclusive sell-side advisor based on its expertise within the industrial distribution and chemicals sectors, relationship with Shrieve and proven M&A execution capabilities.

Recent Deals

July 2025

a portfolio company of 

and

$1.815 Billion

Senior Secured Credit Facilities

$900 Million

8.50% First Lien Secured Notes due 2032

Joint Lead Arranger
Joint Bookrunner

radiology-partners
June 2025

 

El Camino Commons

$74.8 Million

Construction Loan & LIHTC Equity

el-camino-commons
June 2025

Hill Estates

Hill Estates

$67.5 Million

Bridge to Perm Loan, Acquisition

hill-estates
June 2025

thermogenics

a portfolio company of

audax

acquired by

morgan stanley

Sell-Side Advisor

thermogenics

Connect With Us

Find an Expert